Great question. If the patient’s main bother is weak stream, getting a flow rate as baseline is wise. Most MIST treatments have a greater impact on IPSS score rather than flow rate. Can better inform pt and do #SDM.
Optilume may be an exception @MaleHealthDoc
Set expectations appropriately
Awesome first case at Ohio State with Dr. Springer. Optilume BPH will continue to be a great option for those suffering from BPH. Happy to represent it! @LABORIEMEDICAL @OptiDCB @OSU_Urology
#CUAJVideo Dr. Steven A. Kaplan discusses: Long-term outcomes after treatment with Optilume BPH: 4-year results from the EVEREST study.
To read article click here: https://t.co/m7oVtSyKPv
@IcahnMountSinai#BPH#LUTS